PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [75]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2999816

  Achievement of Remission Defined by Absence of Objective Signs of Inflammation versus ASDAS ID in Patients with Active Axial Spondyloarthritis Treated with Bimekizumab: 52-Week Results from Two Phase 3 Studies
  Gensler LS, Marzo-Ortega H, Taieb V, Voiniciuc D, Marten A, Stojan G, Kim M, Rudwaleit M (2024)
  In: 2024 Abstract Supplement ACR Convergence 2024 November 15–19, 2024 Washington, DC. Arthritis & Rheumatology , 76(Suppl. 9). Hoboken: Wiley: 4772-4775.

  PUB | DOI | WoS
   
• [74]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2999818

  Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials
  van der Horst-Bruinsma IE, Brown MA, van Gaalen F, Haroon N, Gensler LS, Marten A, Manente M, Stojan G, Vaux T, White K, Deodhar A, et al. (2024)
  In: 2024 Abstract Supplement ACR Convergence 2024 November 15–19, 2024 Washington, DC. Arthritis & Rheumatology , 76(Suppl. 9). Hoboken: Wiley: 4741-4743.

  PUB | DOI | WoS
   
• [73]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2999819

  The Classification in Axial Spondyloarthritis Inception Cohort Study: Performance of the 2009 Assessments in Spondyloarthritis International Society Classification Criteria
  Maksymowych W, van der Heijde D, Caplan L, Landewé R, Gensler LS, Machado PM, Sepriano A, van Gaalen F, van Lunteren M, Vandermeer B, Sieper J, et al. (2024)
  In: 2024 Abstract Supplement ACR Convergence 2024 November 15–19, 2024 Washington, DC., 76(Suppl. 9). Hoboken: Wiley: 1720-1722.

  PUB | DOI | WoS
   
• [72]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2999823

  Sustained Improvements with Bimekizumab in Patient-Reported Symptoms of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
  Marzo-Ortega H, Mease P, Dougados M, Dubreuil M, Magrey M, Rudwaleit M, D'Agostino MA, de la Loge C, Massow U, Taieb V, Voiniciuc D, et al. (2024)
  In: 2024 Abstract Supplement ACR Convergence 2024 November 15–19, 2024 Washington, DC. Arthritis & Rheumatology , 76(Suppl. 9). Hoboken: Wiley: 1209-1213.

  PUB | DOI | WoS
   
• [71]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2999535

  Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials
  Rudwaleit M, Brown MA, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, et al. (2024)
  Rheumatology 63(1): P163.

  PUB | DOI | WoS
   
• [70]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2993910

  Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis
  Baraliakos X, Machado PM, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2024)
  RMD Open 10(3): e003886.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [69]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993104

  Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials
  Bessette L, Rudwaleit M, Brown M, van Gaalen F, Haroon N, Gensler L, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, et al. (2024)
  Journal of Rheumatology 51(Suppl. 1): 67-68.

  PUB | DOI | WoS
   
• [68]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2992549

  Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis
  Rudwaleit M, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, de Peyrecave N, Kim M, van den Bosch F (2024)
  RMD Open 10(3): e004369.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [67]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990625

  Reporting Sacroiliac Joint Imaging Performed for Known or Suspected Axial Spondyloarthritis: Assessment of SpondyloArthritis International Society Recommendations
  Diekhoff T, Eshed I, Giraudo C, Haibel H, Hermann KGA, de Hooge M, Jans L, Jurik AG, Lambert RG, Machado P, Mallinson M, et al. (2024)
  Radiology 311(3): e231786.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [66]
  

  2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2991327

  Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
  Brown MA, Rudwaleit M, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, et al. (2024)
  Annals of the Rheumatic Diseases.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [65]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990777

  Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies
  Dubreuil M, Navarro-Compán V, Boonen A, Gaffney K, Gensler LS, de la Loge C, Vaux T, Fleurinck C, Massow U, Taieb V, Morup MF, et al. (2024)
  RMD Open 10(2): e004202.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [64]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990773

  Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
  Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Marzo-Ortega H, Navarro-Compán V (2024)
  Rheumatology 63(Suppl. 1): keae163295.

  PUB | DOI | WoS
   
• [63]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990776

  Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
  Rudwaleit M, Brown MA, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, et al. (2024)
  Rheumatology 63(Suppl. 1): keae163202.

  PUB | DOI | WoS
   
• [62]
  

  2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2989903

  Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status
  Rudwaleit M, Deodhar A, Bauer L, Gensler L, Hoepken B, Kumke T, Auteri SE, Kim M, Maksymowych W (2024)
  RMD Open 10(2): e003884.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [61]
  

  2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2988661

  HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis
  Braun J, Märker-Hermann E, Rudwaleit M, Sieper J (2024)
  Annals of the Rheumatic Diseases.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [60]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993463

  Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies
  Mease PJ, Dougados M, Dubreuil M, Magrey MN, Marzo-Ortega H, Rudwaleit M, de la Loge C, Fleurinck C, Massow U, Taieb V, Deodhar A (2023)
  In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 996-1000.

  PUB | DOI | WoS
   
• [59]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993460

  Low Uveitis Rates in Patients with Axial Spondyloarthritis Treated with Bimekizumab: Pooled Results from Phase 2b/3 Trials
  Rudwaleit M, Brown MA, Van Gaalen F, Haroon N, Gensler L, Fleurinck C, Marten A, Massow U, De Peyrecave N, Vaux T, White K, et al. (2023)
  In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 5060-5062.

  PUB | DOI | WoS
   
• [58]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993457

  Work Productivity Improved in Patients with Axial Spondyloarthritis Receiving Bimekizumab Treatment over 52 Weeks: Results from Two Phase 3 Studies
  Rudwaleit M, Navarro-Compán V, Deodhar A, Dubreuil M, Morup MF, Taieb V, de la Loge C, Fleurinck C, Massow U, Vaux T, Boonen A (2023)
  In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 1020-1023.

  PUB | DOI | WoS
   
• [57]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993453

  Factors Associated with Achieving Remission in Patients with Early Peripheral Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort
  Torgutalp M, Peng X, Proft F, Rodriguez VR, Rademacher J, Protopopov M, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2023)
  In: ACR Convergence 2023 Abstract Supplement. Arthritis & Rheumatology , 75(Suppl. 9). Hoboken: Wiley: 4380-4381.

  PUB | DOI | WoS
   
• [56]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993450

  Sustainability of Clinical Response at Week 52 to Upadacitinib Among Patients with Axial SpA: Data from the SELECT-AXIS 1 and SELECT-AXIS 2 Trials
  Navarro-Compán V, Gensler L, Rudwaleit M, Ganz F, Chen S, Stigler J, Schmagel A, Baraliakos X (2023)
  In: ACR Convergence 2023 Abstract Supplement. Arthritis & Rheumatology , 75(Suppl. 9). Hoboken: Wiley: 2739-2741.

  PUB | DOI | WoS
   
• [55]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987166

  An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis
  Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, Kim M, Gensler LS (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 624-625.

  PUB | DOI | WoS
   
• [54]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987167

  Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
  Rudwaleit M, Brown M, Van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, De Peyrecave N, Vaux T, White K, et al. (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 614-615.

  PUB | DOI | WoS
   
• [53]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987168

  Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
  Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, De Peyrecave N, Vaux T, Marzo-Ortega H, Navarro-Compán V (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 875-876.

  PUB | DOI | WoS
   
• [52]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982790

  Long-term clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis stratified by baseline MRI and c-reactive protein status
  Zochling J, Robinson PC, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2023)
  Internal Medicine Journal 53(Suppl. 1): 25.

  PUB | PDF | DOI | WoS
   
• [51]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2988304

  Case report: Cerebral amyloid angiopathy-related inflammation in a patient with granulomatosis with polyangiitis
  Seifert RM, Rauch M, Klingebiel R, Boese L-M, Greeve I, Rudwaleit M, Schäbitz W-R (2023)
  Frontiers in Neurology 14.

  PUB | PDF | DOI
   
• [50]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2985913

  Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis
  Rudwaleit M, Morup M, Humphries B, Zannat N-E, Willems D, Taieb V, Boonen A (2023)
  RMD Open 9(4): e003468.

  PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
   
• [49]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984077

  Patient-reported-Outcomes bei Vaskulitispatienten in Deutschland – Daten aus dem KOBRA-Qualitätsprojekt
  Löffler C, Rudwaleit M, Lakomek H-J, Stammann C, Hellmich B (2023)
  Zeitschrift für Rheumatologie.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [48]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987165

  COMPARISON OF ESTABLISHED AND NEW, PRELIMINARY PROPOSED ASAS CUT-OFFS FOR INFLAMMATORY MRI LESIONS IN THE SACROILIAC JOINTS OF AXIAL SPONDYLOARTHRITIS PATIENTS AND IMPLICATIONS FOR RECRUITMENT IN CLINICAL STUDIES
  Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 621-622.

  PUB | DOI | WoS
   
• [47]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987161

  FACTORS ASSOCIATED WITH ACHIEVING REMISSION IN PATIENTS WITH EARLY PERIPHERAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT (GESPIC)
  Torgutalp M, Peng X, Proft F, Rodriguez VR, Rademacher J, Protopopov M, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 37-38.

  PUB | DOI | WoS
   
• [46]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987156

  QUALITY STANDARDS FOR PATIENTS WITH AXSPA - STATUS QUO OF DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF AXSPA PATIENTS IN GERMANY
  Schmidt JF, Kiltz U, Stammann C, Schubert-Haack J, Strunk J, Lakomek HJ, Braun J, Rudwaleit M (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 1713.

  PUB | DOI | WoS
   
• [45]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2980346

  Changes in diagnosing giant cell arteritis of the temporal artery over a 7.7 year period
  Röchter M, Thiesbrummel S, Marchi H, Fuchs C, Rudwaleit M (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 1579.

  PUB | DOI | WoS
   
• [44]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987172

  IMPLEMENTATION OF QUALITY STANDARDS FOR HEALTH CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS: FIRST RESULTS FROM THE NATIONAL DATABASE OF THE GERMAN COLLABORATIVE ARTHRITIS CENTRES
  Albrecht K, Thiele K, Aringer M, Callhoff J, Karberg K, Krueger K, Lakomek J, Lorenz HM, Rudwaleit M, Schmale-Grede R, Schneider M, et al. (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 868-869.

  PUB | DOI | WoS
   
• [43]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987170

  ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB
  Magrey M, Deodhar A, Mease PJ, Navarro-Compán V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup M, Oortgiesen M, et al. (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 1721.

  PUB | DOI | WoS
   
• [42]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987174

  ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS
  Navarro-Compán V, Benavent D, Capelusnik D, Van der Heijde D, Landewé RBM, Poddubnyy D, Van Tubergen A, Baraliakos X, Van den Bosch F, Van Gaalen FA, Gensler LS, et al. (2023)
  Annals of the Rheumatic Diseases 82(Suppl. 1): 35-36.

  PUB | DOI | WoS
   
• [41]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2986690

  Challenges in the diagnosis of axial spondyloarthritis
  van Gaalen FA, Rudwaleit M (2023)
  Best Practice & Research Clinical Rheumatology 37(3): 101871.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [40]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2985592

  Zur Rolle von HLA-B27 in der Pathogenese und Diagnostik der axialen Spondyloarthritis. 50 Jahre nach Entdeckung der starken genetischen Assoziation
  Braun J, Rudwaleit M, Sieper J (2023)
  Zeitschrift fur Rheumatologie.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [39]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2983818

  Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2
  Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Giger S, Marzo OH, et al. (2023)
  In: Abstracts of the Annual meeting of theSwiss Society of Rheumatology. Swiss Medical Weekly, 153(Suppl. 271). Basel: EMH Schweizerischer Ärzteverlag: 23S.

  PUB | DOI | WoS
   
• [38]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2984578

  Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the Phase 3 studies BE MOBILE 1 and BE MOBILE 2
  Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Sarno A, Marzo-Ortega H, et al. (2023)
  In: Abstract Supplement - 39th Scandinavian Congress of Rheumatology. Scandinavian Journal of Rheumatology , 52(Suppl. 131). Abingdon: Taylor & Francis : 73-74.

  PUB | DOI | WoS
   
• [37]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2982993

  Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis
  Rudwaleit M, Machado PM, Taieb V, de Peyrecave N, Hoepken B, Gensler LS (2023)
  Therapeutic Advances in Musculoskeletal Disease 15.

  PUB | DOI | PubMed | Europe PMC
   
• [36]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982783

  Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs
  Rudwaleit M, Morup M, Humphries B, Zannat NE, Willems D, Taieb V, Boonen A (2023)
  Value in Health 26(6 Suppl.): S397.

  PUB | DOI | WoS
   
• [35]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982796

  Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies
  Bird P, Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, de la Loge C, Ellis A, Fleurinck C, et al. (2023)
  Internal Medicine Journal 53(S2): 24-25.

  PUB | WoS
   
• [34]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968373

  Phänomen der letzten Wiese
  Röchter M-H, Rudwaleit M (2023)
  Zeitschrift fur Rheumatologie.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [33]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968910

  Nachruf der Deutschen Gesellschaft für Rheumatologie (DGRh) auf den Träger der Kussmaul-Medaille der DGRh Prof. Dr. Ernst Feldtkeller
  Braun J, Rudwaleit M, Sieper J, Specker C (2023)
  Zeitschrift für Rheumatologie.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [32]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968388

  Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
  van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, et al. (2023)
  Annals of the Rheumatic Diseases.

  PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
   
• [31]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2969537

  Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled Studies
  Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, de la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, et al. (2022)
  In: ISPOR Europe 2022 Abstracts. Value in Health, 25(12, Suppl.). New York: Elsevier : S427-S428.

  PUB | DOI | WoS
   
• [30]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968210

  Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception Cohort
  Torgutalp M, Rios-Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2946-2948.

  PUB | DOI | WoS
   
• [29]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968211

  Comparison of Established and New, Preliminarily Proposed ASAS Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints of Axial Spondyloarthritis Patients and Implications for Recruitment in Clinical Studies
  Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1997-2000.

  PUB | DOI | WoS
   
• [28]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968213

  Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis
  Brandt-Juergens J, Rudwaleit M, Behrens F, Ritchlin C, Peterlik D, Quebe-Fehling E, Calheiros R, Deodhar A (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2074-2076.

  PUB | DOI | WoS
   
• [27]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968219

  Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study
  Deodhar A, van der Heijde D, Gensler L, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1101-1105.

  PUB | DOI | WoS
   
• [26]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968220

  ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial Spondyloarthritis
  Diekhoff T, Eshed I, Giraudo C, Haibel H, Hermann K-G, de Hooge M, Jans L, Jurik A, Lambert RG, Machado P, Maksymowych WP, et al. (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Reumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 788-790.

  PUB | DOI | WoS
   
• [25]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968222

  ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 Update
  Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewe R, Van den Bosch F, Boteva B, Bremander A, Carron P, et al. (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022 ,November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1094-1097.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [24]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968218

  Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies
  Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, De la Loge C, Ellis A, Fleurinck C, Oortgiesen M, et al. (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatolgy (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 810-813.

  PUB | DOI | WoS
   
• [23]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968217

  MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis
  Maksymowych WP, Ostergaard M, Baraliakos X, Machado P, Pedersen SJ, Weber U, Eshed I, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, et al. (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 4490-4492.

  PUB | DOI | WoS
   
• [22]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968216

  Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies
  Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, et al. (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 814-816.

  PUB | DOI | WoS
   
• [21]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968215

  An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis
  Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compan V, Tham R, Kumke T, Bauer L, Kim M, Gensler L (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1097-1100.

  PUB | DOI | WoS
   
• [20]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968214

  Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status
  Robinson PC, Maksymowych WP, Gensler L, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
  In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 808-810.

  PUB | DOI | WoS
   
• [19]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966738

  MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION
  Navarro-Compan V, Rudwaleit M, De Peyrecave N, Fleurinck C, Oortgiesen M, Taieb V, Baraliakos X (2022)
  Annals of the Rheumatic Diseases 81(Suppl. 1): 771-772.

  PUB | DOI | WoS
   
• [18]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966741

  TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IS ASSOCIATED WITH RETARDATION OF RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT
  Torgutalp M, Rodriguez VR, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
  In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 14-15.

  PUB | DOI | WoS
   
• [17]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966746

  LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
  Robinson P, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
  In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 774-775.

  PUB | DOI | WoS
   
• [16]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966748

  BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY
  Deodhar A, Van der Heijde D, Gensler LS, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
  In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 772-773.

  PUB | DOI | WoS
   
• [15]
  

  2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2965259

  Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort
  Torgutalp M, Rodriguez VR, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
  Arthritis & Rheumatology .

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [14]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2963951

  Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
  Torgutalp M, Rios Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
  Annals of the rheumatic diseases 81(9): 1252-1259.

  PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
   
• [13]
  

  2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2964357

  Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study
  Robinson PC, Maksymowych WP, Gensler LS, Hall S, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, de Peyrecave N, Deodhar A (2022)
  ACR Open Rheumatology.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [12]
  

  2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2963700

  MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group
  Baraliakos X, Ostergaard M, Lambert RG, Eshed I, Machado PM, Pedersen SJ, Weber U, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, et al. (2022)
  Annals of the Rheumatic Diseases.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [11]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2962214

  Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study
  van der Heijde D, Gensler LS, Maksymowych WP, Landewe R, Rudwaleit M, Bauer L, Kumke T, Kim M, Auteri SE, Hoepken B, Deodhar A (2022)
  RMD Open 8(1): e002138.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [10]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961894

  Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?
  Baraliakos X, Rodriguez VR, Torgutalp M, Dilbaryan A, Haibel H, Verba M, Sieper J, Braun J, Rudwaleit M, Poddubnyy D (2021)
  In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 319-321.

  PUB | DOI | WoS
   
• [9]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961900

  Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial Spondyloarthritis
  Maksymowych W, Lambert R, Baraliakos X, Pedersen S, Eshed I, Weber U, Machado P, De Hooge M, Sieper J, Wichuk S, Poddubnyy D, et al. (2021)
  In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1878-1880.

  PUB | DOI | WoS
   
• [8]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961899

  Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal?
  Maksymowych W, Weber U, Baraliakos X, Machado P, Pedersen S, Sieper J, Wichuk S, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe R, et al. (2021)
  In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1876-1878.

  PUB | DOI | WoS
   
• [7]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961897

  Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study
  van der Heijde D, Gensler L, Maksymowych W, Landewe R, Rudwaleit M, Bauer L, Hoepken B, Kumke T, Kim M, Deodhar A (2021)
  In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1896-1899.

  PUB | DOI | WoS
   
• [6]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961896

  Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc Analysis
  Magrey M, Ramiro SA, Pinheiro MM, Gao T, Ganz F, Song I-H, Biljan A, Haroon N, Rudwaleit M (2021)
  In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 1931-1933.

  PUB | DOI | WoS
   
• [5]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961895

  Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial Spondyloarthritis
  Rudwaleit M, Machado P, Gensler L, Taieb V, de Peyrecave N, Hoepken B, van der Heijde D (2021)
  In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 734-738.

  PUB | DOI | WoS
   
• [4]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961892

  Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort
  Torgutalp M, Rodriguez VR, Verba M, Protopopov M, Proft F, Rademacher J, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2021)
  In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 931-933.

  PUB | DOI | WoS
   
• [3]
  

  2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961881

  Association of the improvement of Synovitis and Enthesitis with quality of life/patient reported outcomes in patients with PsA treated with Ixekizumab
  Kristensen LE, McGonagle D, Rudwaleit M, Kameda H, Holzkaemper T, El Baou C, Smolen J (2021)
  In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 3722-3724.

  PUB | DOI | WoS
   
• [2]
  

  2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2959486

  Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
  Maksymowych WP, Kumke T, Auteri SE, Hoepken B, Bauer L, Rudwaleit M (2021)
  Arthritis Research and Therapy 23(1): 274.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [1]
  

  2021 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2958359

  Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in Deutschland
  Kiltz U, Buschhorn-Milberger V, Albrecht K, Lakomek H-J, Lorenz H-M, Rudwaleit M, Schneider M, Schulze-Koops H, Aringer M, Hasenbring MI, Herzer P, et al. (2021)
  Zeitschrift fur Rheumatologie.

  PUB | DOI | WoS | PubMed | Europe PMC